Dudediligence.

Nephros, Inc

NEPHNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Price
FilingsNewest: 13G, Stake over 5%, passiveSep 16 →InsidersNo open-market buys or sales.→HoldersWexford Capital 33.2%Topline 4.9%Vanguard 1.8%→

From the filings

Figures

Revenue
$20.7Mlast 12 months
Net income
$1.7Mlast 12 months
Operating cash flow
−$393,000last 12 months
Cash and equivalents
$4.7Mat the last balance sheet
Shares outstanding
10.9M shareson issue
Every year and quarter →